Aetna Inc. (NYSE:AET) Shares Bought by Honeywell International Inc.

Honeywell International Inc. boosted its holdings in Aetna Inc. (NYSE:AET) by 26.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 192,612 shares of the company’s stock after purchasing an additional 40,100 shares during the period. Honeywell International Inc. owned approximately 0.06% of Aetna worth $30,627,000 at the end of the most recent reporting period.

A number of other institutional investors have also bought and sold shares of AET. Bruderman Asset Management LLC bought a new stake in Aetna in the second quarter worth $106,000. Liberty Capital Management Inc. lifted its stake in Aetna by 206.9% in the second quarter. Liberty Capital Management Inc. now owns 933 shares of the company’s stock worth $144,000 after purchasing an additional 629 shares during the last quarter. Guardian Life Insurance Co. of America lifted its stake in Aetna by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock worth $173,000 after purchasing an additional 9 shares during the last quarter. Westside Investment Management Inc. lifted its stake in Aetna by 53.5% in the second quarter. Westside Investment Management Inc. now owns 1,148 shares of the company’s stock worth $177,000 after purchasing an additional 400 shares during the last quarter. Finally, Phocas Financial Corp. bought a new stake in Aetna in the second quarter worth $182,000. 90.93% of the stock is owned by institutional investors and hedge funds.

In related news, EVP Margaret M. Mccarthy sold 10,288 shares of the stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the transaction, the executive vice president now owns 33,563 shares in the company, valued at $5,465,734.55. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, President Karen S. Lynch sold 15,271 shares of the stock in a transaction that occurred on Monday, September 18th. The shares were sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the transaction, the president now owns 64,261 shares in the company, valued at approximately $10,404,498.51. The disclosure for this sale can be found here. 1.14% of the stock is owned by corporate insiders.

A number of equities analysts have issued reports on AET shares. BidaskClub cut shares of Aetna from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 19th. Argus restated a “buy” rating and issued a $185.00 price objective (up previously from $165.00) on shares of Aetna in a research report on Tuesday, September 12th. Zacks Investment Research upgraded shares of Aetna from a “hold” rating to a “buy” rating and set a $174.00 price objective on the stock in a research report on Thursday, October 12th. Citigroup Inc. boosted their price objective on shares of Aetna from $183.00 to $197.00 and gave the company a “buy” rating in a research report on Thursday, November 2nd. Finally, Deutsche Bank AG boosted their price objective on shares of Aetna from $157.00 to $163.00 and gave the company a “hold” rating in a research report on Monday, August 7th. Eleven equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $172.36.

ILLEGAL ACTIVITY NOTICE: “Aetna Inc. (NYSE:AET) Shares Bought by Honeywell International Inc.” was reported by Week Herald and is owned by of Week Herald. If you are reading this article on another website, it was illegally copied and republished in violation of international copyright and trademark laws. The original version of this article can be viewed at https://weekherald.com/2017/11/15/honeywell-international-inc-purchases-40100-shares-of-aetna-inc-aet.html.

Aetna Inc. (AET) opened at $171.83 on Wednesday. The stock has a market cap of $56,030.00, a P/E ratio of 17.15, a PEG ratio of 1.60 and a beta of 0.61. Aetna Inc. has a 52 week low of $116.04 and a 52 week high of $184.98. The company has a quick ratio of 0.53, a current ratio of 0.53 and a debt-to-equity ratio of 0.52.

Aetna (NYSE:AET) last issued its earnings results on Tuesday, October 31st. The company reported $2.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.06 by $0.39. The firm had revenue of $14.99 billion for the quarter, compared to the consensus estimate of $15.12 billion. Aetna had a net margin of 2.93% and a return on equity of 21.84%. The business’s revenue was down 5.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.07 earnings per share. research analysts forecast that Aetna Inc. will post 9.78 EPS for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 27th. Investors of record on Thursday, October 12th were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Wednesday, October 11th. This represents a $2.00 dividend on an annualized basis and a yield of 1.16%. Aetna’s dividend payout ratio (DPR) is 36.97%.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply